OptiNose Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 144

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 14

OptiNose General Information

Description

OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Corporate Office
  • 777 Township Line Road
  • Suite 300
  • PA 19067
  • United States
+1 (267)
Primary Industry
Drug Delivery
Other Industries
Other Devices and Supplies
Biotechnology
Parent Company
Former Stock Listing
OPTN
Corporate Office
  • 777 Township Line Road
  • Suite 300
  • PA 19067
  • United States
+1 (267)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OptiNose Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore OptiNose‘s full profile, request access.

Request a free trial

OptiNose Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for pati
Drug Delivery
PA
144 As of 2025

Watertown, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OptiNose Competitors (1)

One of OptiNose’s competitors is Lyra Therapeutics, a Formerly VC-backed company based in Watertown, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lyra Therapeutics Formerly VC-backed Watertown, MA
You’re viewing 1 of 1 competitors. Get the full list »

OptiNose Patents

OptiNose Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230285278-A1 Methods for treating chronic rhinosinusitis Pending 06-Mar-2022
US-20220296825-A1 Exhalation delivery system for and method of treating sinus disease Pending 04-Oct-2018
WO-2020070321-A2 Exhalation delivery system for and method of treating sinus disease Inactive 04-Oct-2018
US-10360233-B2 In-memory key-value store for a multi-model database Active 19-Nov-2015
US-20170147664-A1 In-memory key-value store for a multi-model database Active 19-Nov-2015 G06F16/258
To view OptiNose’s complete patent history, request access »

OptiNose Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OptiNose Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore OptiNose‘s full profile, request access.

Request a free trial

OptiNose FAQs

  • When was OptiNose founded?

    OptiNose was founded in 2010.

  • Where is OptiNose headquartered?

    OptiNose is headquartered in PA.

  • What is the size of OptiNose?

    OptiNose has 144 total employees.

  • What industry is OptiNose in?

    OptiNose’s primary industry is Drug Delivery.

  • Is OptiNose a private or public company?

    OptiNose is a Private company.

  • What is the current valuation of OptiNose?

    The current valuation of OptiNose is .

  • What is OptiNose’s current revenue?

    The current revenue for OptiNose is .

  • How much funding has OptiNose raised over time?

    OptiNose has raised $664M.

  • Who are OptiNose’s investors?

    Avista Healthcare Partners, Entrepreneurs Fund, Fidelity Management & Research Company, Foresite Capital, and IKOS Asset Management are 5 of 10 investors who have invested in OptiNose.

  • Who are OptiNose’s competitors?

    Lyra Therapeutics is a competitor of OptiNose.

  • When was OptiNose acquired?

    OptiNose was acquired on 21-May-2025.

  • Who acquired OptiNose?

    OptiNose was acquired by Paratek Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process